全球心包膜穿刺术市场规模、份额、趋势和成长分析报告（2026-2034年）

心包穿刺市场预计将从 2025 年的 13.1 亿美元成长到 2034 年的 21.9 亿美元，2026 年至 2034 年的复合年增长率为 5.87%。

由于需要紧急排放心包膜腔积液的心血管併发症不断增加，全球心包膜穿刺术市场正稳定成长。心包膜穿刺术是一种用于清除心臟周围积液、缓解压力并恢復正常心臟功能的医疗程序。人们对先进心臟护理的认识不断提高以及医院急诊医疗服务的改善，正推动着该手术在临床实践中的应用日益广泛。

推动市场成长的因素有很多，包括心臟病、感染疾病和癌症相关的心包储存率不断上升。医院和心臟中心越来越多地采用先进的影像技术，例如心臟超音波图和超音波引导，以提高手术的安全性和准确性。医疗基础设施的扩建和对心血管护理投入的增加也推动了心包穿刺术专用设备的应用。

随着医疗技术的不断进步，心臟治疗效果持续提升，市场前景依然乐观。微创器械的研发和导管设计的改进有望提高手术效率和病人安全性。新兴市场心臟护理服务的拓展将为医疗服务提供者创造更多机会。随着全球心血管疾病发生率的持续上升，对心包膜穿刺术等高效急救手术的需求预计将会增加。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球心包膜穿刺市场：依手术类型划分

• 市场分析、洞察与预测
• 紧急心包穿刺术
• 选择性心包膜穿刺术

第五章：全球心包穿刺技术市场：依引导法划分

• 市场分析、洞察与预测
• 超音波心动图引导
• 在透视下
• CT引导

第六章：全球心包膜穿刺技术市场：依应用领域划分

• 市场分析、洞察与预测
• 心臟压塞
• 心膜炎
• 心包膜储存

第七章：全球心包穿刺技术市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 专科诊所

第八章 全球心包穿刺市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Siemens Healthineers
  • Baxter International
  • Roche
  • GE Healthcare
  • Johnson And Johnson
  • Medtronic
  • Boston Scientific
  • Hologic
  • Terumo Corporation
  • Philips Healthcare
  • Cpachealth
  • Abbott Laboratories
  • Braun Melsungen
  • Stryker
  • Cardinal Health

The Pericardiocentesis Procedures Market size is expected to reach USD 2.19 Billion in 2034 from USD 1.31 Billion (2025) growing at a CAGR of 5.87% during 2026-2034.

The global pericardiocentesis procedures market has grown steadily due to increasing cases of cardiovascular complications that require emergency fluid drainage from the pericardial sac. Pericardiocentesis is a medical procedure used to remove excess fluid around the heart, helping relieve pressure and restore normal cardiac function. Rising awareness about advanced cardiac care and improvements in hospital emergency services have contributed to the increased use of this procedure in clinical settings.

Several factors are driving market growth, including the rising prevalence of heart diseases, infections, and cancer-related pericardial effusions. Hospitals and cardiac centers are increasingly adopting advanced imaging technologies such as echocardiography and ultrasound guidance to improve procedural safety and accuracy. Growing healthcare infrastructure and increasing investments in cardiovascular care are also encouraging the adoption of specialized equipment used during pericardiocentesis procedures.

The future outlook for the market remains promising as medical technologies continue to enhance cardiac treatment outcomes. The development of minimally invasive tools and improved catheter designs may increase procedural efficiency and patient safety. Expanding cardiac care services in emerging economies will likely create additional opportunities for healthcare providers. As cardiovascular disease rates continue to rise globally, demand for effective emergency procedures such as pericardiocentesis is expected to grow.

MARKET SEGMENTATION

By Procedure Type

• Emergency Pericardiocentesis
• Elective Pericardiocentesis

By Guidance Method

• Echocardiography-Guided
• Fluoroscopy-Guided
• CT-Guided

By Application

• Cardiac Tamponade
• Pericarditis
• Pericardial Effusion

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

COMPANIES PROFILED

• Siemens Healthineers, Baxter International, Roche, GE Healthcare, Johnson and Johnson, Medtronic, Boston Scientific, Hologic, Terumo Corporation, Philips Healthcare, Cpachealth, Abbott Laboratories, Braun Melsungen, Stryker, Cardinal Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Procedure Type
• 4.2. Emergency Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Elective Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY GUIDANCE METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Guidance Method
• 5.2. Echocardiography-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Fluoroscopy-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. CT-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiac Tamponade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pericarditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pericardial Effusion Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Procedure Type
  • 8.2.2 By Guidance Method
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Procedure Type
  • 8.3.2 By Guidance Method
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Procedure Type
  • 8.4.2 By Guidance Method
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Procedure Type
  • 8.5.2 By Guidance Method
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Procedure Type
  • 8.6.2 By Guidance Method
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PERICARDIOCENTESIS PROCEDURES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Siemens Healthineers
  • 10.2.2 Baxter International
  • 10.2.3 Roche
  • 10.2.4 GE Healthcare
  • 10.2.5 Johnson And Johnson
  • 10.2.6 Medtronic
  • 10.2.7 Boston Scientific
  • 10.2.8 Hologic
  • 10.2.9 Terumo Corporation
  • 10.2.10 Philips Healthcare
  • 10.2.11 Cpachealth
  • 10.2.12 Abbott Laboratories
  • 10.2.13 Braun Melsungen
  • 10.2.14 Stryker
  • 10.2.15 Cardinal Health